Cart
sales@molnova.com
Soyasaponin Ba
CAS No. 114590-20-4
Soyasaponin Ba( —— )
Catalog No. M23328 CAS No. 114590-20-4
Soyasaponin Ba may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 277 | In Stock |
|
| 5MG | 157 | In Stock |
|
| 10MG | 269 | In Stock |
|
| 25MG | 455 | In Stock |
|
| 50MG | 638 | In Stock |
|
| 100MG | 886 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSoyasaponin Ba
-
NoteResearch use only, not for human use.
-
Brief DescriptionSoyasaponin Ba may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects.
-
DescriptionSoyasaponin Ba may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects.Soyasaponins Ab and Bb prevent scopolamine-induced memory impairment in mice without the inhibition of acetylcholinesterase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptoracetylcholinesterase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114590-20-4
-
Formula Weight959.1
-
Molecular FormulaC48H78O19
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@]12CC[C@@H]([C@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(C[C@H]5O)(C)C)C)C)C)(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ac-Leu-Lys-Phe-Ser-L...
Ac-Leu-Lys-Phe-Ser-Lys-Lys-Phe-OH
-
N-Methyl-1-deoxynoji...
N-Methylmoranoline (MOR 14) is an α-glucosidase inhibitor.
-
D-Glucose 6-phosphat...
In cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.
